Sharecafe

Alterity Therapeutics (ASX:ATH) – Webinar Presentation

Dr David Stamler, CEO, Alterity Therapeutics (ASX:ATH) is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.
Video Player is loading.
Current Time 0:00
Duration 17:45
Loaded: 0.94%
Stream Type LIVE
Remaining Time 17:45
 
1x

 

Dr David Stamler – CEO – Alterity Therapeutics (ASX:ATH) is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories